GEXVal CEO Selected as Invited Speaker at CPHI Japan 2026
wpmaster
GEXVal Inc.
April 15, 2026
GEXVal CEO Selected as Invited Speaker at Drug Discovery Symposium of CPHI Japan 2026
GEXVal Inc. (President & CEO・Chief Scientific Officer : Juran Kato, PhD; Fujisawa, Kanagawa, Japan; hereinafter “GEXVal”) is pleased to announce that Dr. Juran Kato has been invited to speak at the Drug Discovery Symposium of CPHI Japan 2026 (International Pharmaceutical Development Exhibition), hosted by Informa Markets Japan Co., Ltd.
[Event Overview]
CPHI Japan 2026 (International Pharmaceutical Development Exhibition) is an international exhibition bringing together over 800 exhibitors from approximately 30 countries, covering the full value chain from drug discovery to manufacturing and distribution. This year's event will be the largest in the show's history, featuring approximately 250 seminars led by industry key opinion leaders and extensive international business networking opportunities.
This Drug Discovery Symposium brings together speakers across next-generation modalities-including nucleic acid therapeutics, small molecules, antibodies, and regenerative medicine- to examine the current state and future challenges of drug discovery innovation.
GEXVal is presenting the “Next-Generation Small Molecule Drug Discovery” session, addressing how AI-drive, data-centric drug discovery can extend the strength of small molecule therapeutics to broaden access to treatments for rare and underserved diseases-from platform strategy to proposed improvements in the drug discovery ecosystem.
**Presentation Details**
|
Conference |
CPHI Japan 2026 (23rd International Pharmaceutical Development Exhibition) |
|
Event Date |
April 21–23, 2026 |
|
Venue |
Hall 3B (East Hall 3) |
|
Title |
Reaching the Unreached: |
|
URL |
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaches the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
For further information:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com
